Nancy Rudisill, R.N.
|Nancy Rudisill, R.N.
University of Pheonix, Sacramento, Master of Science Focus, 1998
California Board of Registered Nursing; Mobile Intensive Care Nurse Certification, 1997; Trauma Nurse Core Curriculum Provider, Emergency Nurses Association, 1996; Certified Critical Care Registered Nurse, American Association of Critical-Care Nurses, 1992
Research projects ongoing or completed
Title: A double-blind, placebo controlled, multi-center study to evaluate the efficacy and safety of a single intravenous dose of CP-101, 606 in subjects with severe head injury.
Principal Investigator: J. Paul Muizelaar
Agency: Pfizer Pharmaceuticals
Type: Clinical Trial Period: 9/98 to 9/00
Goals: To determine the safety and effectiveness of a single intravenous dose of CP-101, 606 in subjects with severe head injury.
Title: A randomized, double-blind, placebo-controlled study of Cl-1009 in patients with severe head injury.
Principal Investigator: J. Paul Muizelaar, M.D., Ph.D.
Agency: Parke Davis, a division of Warner Lambert
Type: Clinical Trial, CI-1009-002-071 Period: 6/97-6/99
Goals: The major goals are to determine the effectiveness and safety of CI-1009 in patients with severe head injury, and to determine the effects of the drug versus placebo on health-related quality of life, functional status, overall cost of treatment, and how much medication is found in the blood.
Title: A Controlled Multi-Center Clinical Trial to Study the Effectiveness of Systemic Hypothermia in Treatment of Severely Brain Injured Patients.
Principal Investigator: Franklin C. Wagner; Co-P.I.: J. Paul Muizelaar
Type: RO1 NS 32786-04 (Clifton) Period: 7/97-12/98
Goals: To determine the effectiveness and safety of moderate systemic hypothermia in patients with severe head injury, and to determine the effects of hypothermia versus normothermia on outcome after severe head injury.
Professional society membership
American Association of Neuroscience Nurses; Sigma Theta Tau; American Brain Injury Consortium Member, Medical College of Virginia; Human Subjects Review Committee Member, UC Davis; Bio-ethics Hospital Committee Member, UC Davis
|1998||Muizelaar JP, Zwienenberg M, Mini NA, Hecht ST. The safety and efficacy of transluminal balloon angioplasty in the prevention of vasospasm in patients with Fisher Grade II subarachnoid hemorrhage: A pilot study. Neurosurg Focus 5(4): Article 5|
|1999||Muizelaar JP, Zwienenberg M, Rudisill NA, Hecht, ST: The prophylactic use of transluminal balloon angioplasty in patients with Fisher Grade 3 subarachnoid hemorrhage: a pilot study. J. Neurosurg, 91:51-58|